Suzhou Tianma fine chemical co., ltd.

The issuer was initiated by Suzhou Tianma Pharmaceutical Group Co., Ltd. (hereinafter referred to as Tianma Group), Suzhou Guofa Innovation Capital Investment Co., Ltd. (hereinafter referred to as Guofa Venture Capital), Shenzhen Innovation Investment Group Co., Ltd. (hereinafter referred to as Shenzhen Venture Capital), Suzhou Industrial Park Haifu Investment Co., Ltd. (hereinafter referred to as Haifu Investment), Gu Zhiqiang and other 65,438+07 natural persons. Suzhou Tianma Pharmaceutical Group Fine Chemical Co., Ltd. (hereinafter referred to as Tianma Medical Chemical) was registered in Suzhou Administration for Industry and Commerce on February 28th, 2007 with the registration number of 320500000046770. The issuer is a fine chemical enterprise specializing in the research, development, production and sales of various fine chemicals. During the reporting period, the company's main products include AKD series sizing agents (AKD powder, AKD emulsion, etc. ), cationic dispersed rosin size, amino acid protective agent (ester, amine, etc.). ), protect amino acids and meglumine. After nearly ten years of continuous development, the issuer has a number of product series, covering product research and development, process optimization and development, large-scale production, customized processing and production and other complete fine chemical business systems, and has accumulated a number of core technologies such as AKD continuous production and rich industrial production management experience. It is a first-class competitive fine chemical professional manufacturer in China. According to the survey and statistics of China Chemical Information Center, in recent years, the market share and ranking of the issuer's main products, AKD raw powder, methyl ester and methylamine, are in the forefront of the country, with obvious industry position and market leading edge. The issuer is a high-tech enterprise in Jiangsu Province, with advanced specialized production, analysis and testing equipment and strong independent research and development strength. The issuer has national invention patents such as "production method of alkyl ketene dimer (AKD)" and "production method of nano silica sol for papermaking" and more than ten core technologies of major products, and has been responsible for drafting and formulating the national standard of raw powder of alkyl ketene dimer (AKD) since 2009. The main customers of a series of fine chemicals for papermaking include nine dragons paper, Chenming Paper and Liwen Paper (2008). At the same time, relying on strong technical strength and excellent product quality, the issuer has passed Bayer (German Bayer, one of the largest chemical and health care enterprises in the world), Wyeth (American Wyeth, one of the largest basic drugs and health care products enterprises in the world), BACHEM (Swiss Baheng, the largest manufacturer of R&D and polypeptide raw materials in the world), Merck &; The supplier qualification certification of more than ten famous multinational companies, such as Co. (Merck, a world-famous multinational pharmaceutical company), has become one of the important process development and production bases in China, forming a stable and close cooperative supply chain relationship.